Affordable Access

Publisher Website

HLA-G expression in transitional bladder carcinoma. Relationship with tumor invasion level and patient survival: Experience in a public hospital in Argentina.

Authors
  • Moavro, Damián E1
  • Andrini, Laura2
  • Iribarne, Ailén2
  • Colaci, Pablo2
  • García, Marcela2
  • 1 Cátedra de Citología, Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Buenos Aires, Argentina; Hospital Interzonal General de Agudos "General San Martín", La Plata, Provincia de Buenos Aires, Argentina. Electronic address: [email protected]. , (Argentina)
  • 2 Cátedra de Citología, Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de La Plata. Buenos Aires, Argentina. , (Argentina)
Type
Published Article
Journal
Human immunology
Publication Date
Aug 01, 2023
Volume
84
Issue
8
Pages
423–427
Identifiers
DOI: 10.1016/j.humimm.2023.03.008
PMID: 37069040
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Transitional carcinoma (TC) is the most common neoplasm of the bladder (80%). The immune checkpoint (IC) Human leukocyte antigen G (HLA-G) expression has been demonstrated within numerous types of cancer and correlates with the degree of malignancy. This study aims for HLA-G expression in the bladder TC in a public hospital in Argentina linking its malignancy grade with the survival of the patients. We study thirty TC samples, in which we determine the invasion level and the HLA-G expression by immunohistochemistry. From all analyzed cases, 23 correspond to high-grade TC, of whom 91% presented HLA-G immunostaining and 83% compromised the muscularis propria layer of the bladder. Four patients in this group have not exceeded 5 years of survival. This data confirms that HLA-G expression in the bladder TC is associated with greater aggressiveness. Therefore, adding this immunostaining to the immunohistochemical panel used in the routine diagnosis of this neoplasm would be very useful. Copyright © 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Report this publication

Statistics

Seen <100 times